David T (@davidterrero) header
David T (@davidterrero) profile picture

Domin'iowan 🇩🇴🇺🇸 Papi de Cam y C-man Infectologo/ ID physician

United States
Joined October 2009
Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)Photo by David T (@davidterrero)
Happy 2000th episode! Been a fan i think since 2020 @StarthereABC
20
🔥Just published🔥 @TheLancetInfDis British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update #IDXposts Thanks @Inox94 thelancet.com/journals/lanin…
4
157
1
380
38,166
Quite dissapointed with @StubHub claim review n lack of clear answers. Sell process via app was far from streamlined nintuitive, pervasive and frankly dissapointing. Sell didng go thru, tickets went to waste, and on top, had extra charge for sell not working #ticketscam @viagogo
5
1
5
520
But My White Count…⁦@NEJM⁩ “The white count is up. Should we broaden antibiotics?” Great perspective by Robin Colgrove. So many times I am asked this question during consults and most of the time the answer is NO! ⁦@IDSAInfo⁩ nejm.org/doi/full/10.1056/NE…
10
51
5,807
【Management of Candida auris】@JAMA_current Jan 22, 2024 👉Today’s 5-min read! ✍️Fluconazole-R: 86-100% ✍️Polyene-R: 43% ✍️Echinocandin-R: 2-5% jamanetwork.com/journals/jam… #IDFellow #IDMedEd @MSG_ERC @DrFungus_MSGERC
1
80
3
200
15,305
Do you have a patient with persistent low-level HIV viremia and not sure why? We've got a new paper in @NatureMedicine exploring the reasons behind this phenomenon of non-suppressible viremia (NSV). Read on 👇 to hear about what we found! nature.com/articles/s41591-0…
6
62
8
194
57,240
Publication Alert This systematic review and individual patient data meta-analysis concluded that TMP-SMX prophylaxis reduces the risk of nocardiosis in solid organ transplant recipients @ZYetmar @MatteoPasserin6 @CMIJournal bit.ly/4935X76
1
27
62
8,257
#IDWeek2023  UTI in Renal Tx R  37.8% bacteremia in UTI with KTRx  No Sx, No UTI  Can treating ASB decrease pyelonephritis? “Not 1st 2months”  - Not really ➡️more resistant bugs!  Optimal duration in IC pts? 7 vs 14 d?  Rec UTI: Voiding cystourethrogram w neg imaging
2
40
1
104
14,144
IDWeek2023  SABATO TRIAL:  Hosp with SA BSI, majority MSSA    IVàPO may be an option  But limitations!!!  Bioavailability and issue penetration (AUC/MIC)!    POET Substudy, which drugs, bugs and target attainment
1
46
2
136
65,011
REPRIEVE trial published ! ➡️Pitavastatin to Prevent Cardiovascular Disease in HIV Infection nejm.org/doi/full/10.1056/NE… #IAS2023 #HIVtwitter #IDTwitter @ABsteward #REPRIEVE #REPRIEVETrial
1
11
3
36
7,952
Best game I've witnessed in a long time! - across all sports! go @IowaWBB !!!
"THE HAWKEYES ARE HEADED TO THE NCAA CHAMPIONSHIP GAME." @IowaWBB is set to play in their first NCAA Championship Game on Sunday versus LSU. 😱
1
131
Goin' to the 'ship 😤 @IowaWBB x #Hawkeyes
19
192
21
2,846
103,004
Goodnight, Dawn Staley. Sweet dreams.
41
555
22
5,332
310,946
What.a.game!!!! @TheIowaHawkeyes @Iowabasketball @CaitlinClark22 dominated like a boss. It was all great energy and amazing sport spirit all the way from both teams 🙌😎
43
New #PrEP @CDC_HIV guidelines seem to have quitely changed rec sending HIV viral too for screening on q3 mont f/u, specially if taking #Cabotegravir based on @HIVptn 083 data due to diagnostic lag of Ab/Ag testing vs PCR. Have you adopted this? #IDtwitter @IDSAInfo @HIVMA
67%Yes, sending PCR too
0%Yes, in high risk pts
0%No, it's expensive
33%No, need more data
3 votes • Final results
1
1
159
One of my objectives in 2023 is to learn R. Does anyone know of a course or a book for beginner-beginners?
228
477
39
4,776
1,082,371
Bacteremia due to Non-Staphylococcus aureus Gram-positive Cocci and Risk of Cardiovascular Implantable Devices Infection. @MayoClinicINFD @bcmhouston @BCMIDFellowship #IDtwitter #CIEDInfection doi.org/10.1093/ofid/ofac492…
6
56
4,944